Skip to main content
Equibles
TKNO logo

TKNO · Alpha Teknova, Inc. · Metrics

Track TKNO — free

Use TKNO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TKNO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.42 +0.27 (+4.39%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$344.68M
Shares
53.69M
Volume · Oct 23 875.79K Avg daily vol (3M) 367.58K

TKNO metrics

88 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$6.42
Market cap
$344.68M

Price action

20 metrics
Price change (1W)
-9.3%
Price change (30D)
-31.2%
Price change (3M)
+29.2%
Price change (6M)
+101.9%
Price change (YTD)
+68.9%
Price change (1Y)
+11.5%
Trailing year
Price change (5Y)
-73.0%
52-week high
$9.33
52-week low
$1.99
Change from 52-week high
-31.2%
Change from 52-week low
+222.6%
Annualized volatility
79.4%
Annualized volatility (3M)
77.2%
Beta
1.3
RSI (14D)
37.0
Price vs SMA 50
-16.4%
Price vs SMA 200
+33.7%
Avg volume (3M)
367,578
Relative volume
2.4
Average dollar volume
$2.60M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
53.69M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
7.8×
reciprocal yield 12.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
7.9×
reciprocal yield 12.7%
P / book
5.5
reciprocal yield 18.2%
FCF yield
-2.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-4.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
5.3×
reciprocal yield 18.9%
EV / revenue historical average (5Y)
5.3×
reciprocal yield 18.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
34.6%
Operating margin
-36.2%
Trailing 12 months
Net margin
-38.4%
Gross profit (TTM)
$15.12M
Operating profit (TTM)
−$15.81M
Net income (TTM)
−$16.77M
Trailing 12 months
Diluted EPS (TTM)
$-0.30
FCF margin
-16.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.82
Gross profit per diluted share (TTM)
$0.28
Operating profit per diluted share (TTM)
$-0.30
EBITDA per diluted share (TTM)
$-0.18
Net income per diluted share (TTM)
$-0.31
Operating cash flow per diluted share (TTM)
$-0.12
Free cash flow per diluted share (TTM)
$-0.14
Capital expenditures per diluted share (TTM)
$0.02
R&D per diluted share (TTM)
$0.04
Stock compensation per diluted share (TTM)
$0.05
Book value per share
$1.28

Growth

11 metrics
Revenue growth YoY
+18.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$43.70M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.3%
Year over year · more shares
Revenue CAGR (3Y)
-0.7%
Revenue CAGR (5Y)
+5.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-26.8%
Return on assets
-17.5%
Debt / equity
0.2
Current ratio
4.5
EBITDA (TTM)
−$9.47M
Free cash flow (TTM)
−$7.35M
Quick ratio
3.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$4.22M
Latest balance sheet
Cash & equivalents
$6.00M
Total assets
$95.88M
Total debt
$13.22M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$6.27M
Capital expenditures (TTM)
$1.08M
R&D (TTM)
$2.23M
SG&A (TTM)
—
Stock compensation (TTM)
$2.94M
R&D / revenue
5.1%
Stock compensation / revenue
6.7%

Ownership (13F)

9 metrics
13F filers
79
13F filer change QoQ
+1
Institutional ownership
17.0%
Conviction holders (share of 13F filers)
1.3%
Crowding (high-turnover and private-fund holders)
7.2%
Private-fund adviser ownership
7.1%
Active holders' share change QoQ
+1.2%
Holder tenure
7.5
Price vs estimated holder cost
+28.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
4.9%

Short interest

3 metrics
Short interest
3.0%
Latest settlement · 4.8 days to cover
Days to cover
4.8d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1850902 CUSIP 02080L102 13F (30d) 8 filings 8 filers Visit website Investor relations